Press Releases
Friday, June 4, 2010
BUFFALO, NY — Researchers at Roswell Park Cancer Institute (RPCI) are hoping to determine whether genetic profiling may effectively identify which breast cancer patients are most likely to respond to the drug trastuzumab. Preliminary research findings will be summarized by lead investigator Thaer...
Read more
Friday, June 4, 2010
BUFFALO, NY — Gene expression profiling, combined with a novel chemoradiation regimen, may predict pathologic complete response in patients with esophageal cancer, according to research conducted at Roswell Park Cancer Institute (RPCI) and M. D. Anderson Cancer Center. Nikhil Khushalani, MD, an...
Read more
Friday, June 4, 2010
BUFFALO, NY — Overweight or obese Hodgkin’s lymphoma patients who receive standard chemotherapy may experience poorer outcomes than those patients with body mass indices of less than 25, according to a retrospective analysis conducted by researchers at Roswell Park Cancer Institute (RPCI). First...
Read more
Friday, June 4, 2010
RPCI, Komen WNY Race for the Cure encourage donations to specimen databank.
BUFFALO, NY — In collaboration with the 2010 Susan G. Komen Western New York Race for the Cure, Roswell Park Cancer Institute (RPCI) will collect saliva specimens for its Data Bank and BioRepository (DBBR) at the June 12...
Read more
Thursday, June 3, 2010
Goal of drive is to secure 10,000 signed consent forms from hospital and health plan employees, Drive continues the momentum from recent $16.1 million Beacon Community Award from Obama Administration to HEALTHeLINK.
The CEOs of the region’s leading hospital systems and health plans who also...
Read more
Wednesday, June 2, 2010
Representatives from Roswell Park Cancer Institute and Marrano/Marc Equity joined in a ribbon cutting ceremony today as they launched the fundraising partnership, Raising the Roof for Groundbreaking Cancer Research. Two previous Raising the Roof partnerships generated $160,000 in each year to...
Read more
Tuesday, June 1, 2010
BUFFALO, NY - About half of all cancer patients with metastatic disease will develop malignant pleural effusions (MPE), which result in significant respiratory challenges and a poorer overall quality of life. A lack of research data has hampered physicians’ efforts to effectively manage MPE...
Read more
Friday, May 28, 2010
BUFFALO, NY — Two Buffalo scientists have paired up to create technology that has the potential to revolutionize surgical training worldwide, developing the first procedure-based, hands-on surgical training software. Their patent-pending system, Hands-On Surgical Training ™ (HOST),...
Read more
Thursday, May 27, 2010
BUFFALO, NY — A Buffalo-based international expert on robot-assisted surgical techniques has created the first-ever virtual instructional manual on robot-assisted surgery. The interactive guide, “Operative Manual of Robot-Assisted Urologic Surgery,” edited by Khurshid A. Guru,...
Read more
Wednesday, May 26, 2010
Buffalo, NY — Men with metastatic prostate cancer who received the new biologic agent tasquinimod (TASQ) saw their progression-free survival time double compared to men who received a placebo, according to initial findings of a phase II clinical study to be presented by Roberto Pili, MD,...
Read more
